222 related articles for article (PubMed ID: 26486513)
1. A Comparison of the Pharmacokinetics and Pulmonary Lymphatic Exposure of a Generation 4 PEGylated Dendrimer Following Intravenous and Aerosol Administration to Rats and Sheep.
Ryan GM; Bischof RJ; Enkhbaatar P; McLeod VM; Chan LJ; Jones SA; Owen DJ; Porter CJ; Kaminskas LM
Pharm Res; 2016 Feb; 33(2):510-25. PubMed ID: 26486513
[TBL] [Abstract][Full Text] [Related]
2. PEGylated polylysine dendrimers increase lymphatic exposure to doxorubicin when compared to PEGylated liposomal and solution formulations of doxorubicin.
Ryan GM; Kaminskas LM; Bulitta JB; McIntosh MP; Owen DJ; Porter CJH
J Control Release; 2013 Nov; 172(1):128-136. PubMed ID: 23954628
[TBL] [Abstract][Full Text] [Related]
3. Doxorubicin Conjugation and Drug Linker Chemistry Alter the Intravenous and Pulmonary Pharmacokinetics of a PEGylated Generation 4 Polylysine Dendrimer in Rats.
Leong NJ; Mehta D; McLeod VM; Kelly BD; Pathak R; Owen DJ; Porter CJH; Kaminskas LM
J Pharm Sci; 2018 Sep; 107(9):2509-2513. PubMed ID: 29852134
[TBL] [Abstract][Full Text] [Related]
4. PEGylation of polylysine dendrimers improves absorption and lymphatic targeting following SC administration in rats.
Kaminskas LM; Kota J; McLeod VM; Kelly BD; Karellas P; Porter CJ
J Control Release; 2009 Dec; 140(2):108-16. PubMed ID: 19686787
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary administration of PEGylated polylysine dendrimers: absorption from the lung versus retention within the lung is highly size-dependent.
Ryan GM; Kaminskas LM; Kelly BD; Owen DJ; McIntosh MP; Porter CJ
Mol Pharm; 2013 Aug; 10(8):2986-95. PubMed ID: 23750747
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate-conjugated PEGylated dendrimers show differential patterns of deposition and activity in tumor-burdened lymph nodes after intravenous and subcutaneous administration in rats.
Kaminskas LM; McLeod VM; Ascher DB; Ryan GM; Jones S; Haynes JM; Trevaskis NL; Chan LJ; Sloan EK; Finnin BA; Williamson M; Velkov T; Williams ED; Kelly BD; Owen DJ; Porter CJ
Mol Pharm; 2015 Feb; 12(2):432-43. PubMed ID: 25485615
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary administration of a doxorubicin-conjugated dendrimer enhances drug exposure to lung metastases and improves cancer therapy.
Kaminskas LM; McLeod VM; Ryan GM; Kelly BD; Haynes JM; Williamson M; Thienthong N; Owen DJ; Porter CJ
J Control Release; 2014 Jun; 183():18-26. PubMed ID: 24637466
[TBL] [Abstract][Full Text] [Related]
8. Lymphatic transport and lymph node targeting of methotrexate-conjugated PEGylated dendrimers are enhanced by reducing the length of the drug linker or masking interactions with the injection site.
Ryan GM; McLeod VM; Mehta D; Kelly BD; Stanislawski PC; Owen DJ; Kaminskas LM; Porter CJH
Nanomedicine; 2017 Nov; 13(8):2485-2494. PubMed ID: 28821463
[TBL] [Abstract][Full Text] [Related]
9. The interaction of dendrimer-doxorubicin conjugates with a model pulmonary epithelium and their cosolvent-free, pseudo-solution formulations in pressurized metered-dose inhalers.
Zhong Q; Humia BV; Punjabi AR; Padilha FF; da Rocha SRP
Eur J Pharm Sci; 2017 Nov; 109():86-95. PubMed ID: 28774811
[TBL] [Abstract][Full Text] [Related]
10. Effect of the Route of Administration and PEGylation of Poly(amidoamine) Dendrimers on Their Systemic and Lung Cellular Biodistribution.
Zhong Q; Merkel OM; Reineke JJ; da Rocha SR
Mol Pharm; 2016 Jun; 13(6):1866-78. PubMed ID: 27148629
[TBL] [Abstract][Full Text] [Related]
11. Targeting the lymphatics using dendritic polymers (dendrimers).
Kaminskas LM; Porter CJ
Adv Drug Deliv Rev; 2011 Sep; 63(10-11):890-900. PubMed ID: 21683746
[TBL] [Abstract][Full Text] [Related]
12. Dendrimer nanocarriers for transport modulation across models of the pulmonary epithelium.
Bharatwaj B; Mohammad AK; Dimovski R; Cassio FL; Bazito RC; Conti D; Fu Q; Reineke J; da Rocha SR
Mol Pharm; 2015 Mar; 12(3):826-38. PubMed ID: 25455560
[TBL] [Abstract][Full Text] [Related]
13. Effect of increased surface hydrophobicity via drug conjugation on the clearance of inhaled PEGylated polylysine dendrimers.
Haque S; McLeod VM; Jones S; Fung S; Whittaker M; McIntosh M; Pouton C; Owen DJ; Porter CJH; Kaminskas LM
Eur J Pharm Biopharm; 2017 Oct; 119():408-418. PubMed ID: 28713018
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and tumor disposition of PEGylated, methotrexate conjugated poly-l-lysine dendrimers.
Kaminskas LM; Kelly BD; McLeod VM; Boyd BJ; Krippner GY; Williams ED; Porter CJ
Mol Pharm; 2009; 6(4):1190-204. PubMed ID: 19453158
[TBL] [Abstract][Full Text] [Related]
15. The impact of molecular weight and PEG chain length on the systemic pharmacokinetics of PEGylated poly l-lysine dendrimers.
Kaminskas LM; Boyd BJ; Karellas P; Krippner GY; Lessene R; Kelly B; Porter CJ
Mol Pharm; 2008; 5(3):449-63. PubMed ID: 18393438
[TBL] [Abstract][Full Text] [Related]
16. Attenuated polyethylene glycol immunogenicity and overcoming accelerated blood clearance of a fully PEGylated dendrimer.
Kojima C; Yao J; Nakajima K; Suzuki M; Tsujimoto A; Kuge Y; Ogawa M; Matsumoto A
Int J Pharm; 2024 Jun; 659():124193. PubMed ID: 38703934
[TBL] [Abstract][Full Text] [Related]
17. Optimal PEGylation can improve the exposure of interferon in the lungs following pulmonary administration.
Mcleod VM; Chan LJ; Ryan GM; Porter CJ; Kaminskas LM
J Pharm Sci; 2015 Apr; 104(4):1421-30. PubMed ID: 25631360
[TBL] [Abstract][Full Text] [Related]
18. The Pharmacokinetics and Biodistribution of a 64 kDa PolyPEG Star Polymer After Subcutaneous and Pulmonary Administration to Rats.
Khor SY; Hu J; McLeod VM; Quinn JF; Porter CJ; Whittaker MR; Kaminskas LM; Davis TP
J Pharm Sci; 2016 Jan; 105(1):293-300. PubMed ID: 26852861
[TBL] [Abstract][Full Text] [Related]
19. PEGylated lysine dendrimers for tumor-selective targeting after intravenous injection in tumor-bearing mice.
Okuda T; Kawakami S; Akimoto N; Niidome T; Yamashita F; Hashida M
J Control Release; 2006 Dec; 116(3):330-6. PubMed ID: 17118476
[TBL] [Abstract][Full Text] [Related]
20. Cellular internalization and transport of biodegradable polyester dendrimers on a model of the pulmonary epithelium and their formulation in pressurized metered-dose inhalers.
Heyder RS; Zhong Q; Bazito RC; da Rocha SRP
Int J Pharm; 2017 Mar; 520(1-2):181-194. PubMed ID: 28161666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
